11-01 :: December 2010 / January 2011
nanotimes
Companies Facts
lator while CIVCOM will develop and manufacture the 40Gb/s RZ-DQPSK SFF transponder. Under the grant, GigOptix will leverage its Thin Film Polymer on Silicon (TFPS™) technology to implement an integrated 40Gb/s RZ-DQPSK optical modulator in a single package. Currently 40Gb/s RZ-DQPSK opti- cal modulation is implemented using two separate Lithium Niobate modulators, the first implements RZ modulation and the second DQPSK modulation. The integrated GigOptix solution will be significantly smaller to the discrete approach with the integrated GigOptix solution being smaller than one of the com- peting Lithium Niobate modulators. Furthermore, GigOptix broadband RF driver and optical modulator teams will optimize the interoperability between the modulator and the driver to enable further reduc- tion in power consumption and overall footprint of the electro-optic transmission system. This size and power reduction will enable CIVCOM to shrink the size of its 40G RZ-DQPSK transponder to the size of current 10G transponders.
On January 06, 2011, the Company announced the resignation of its Chief Financial Officer, Ron Shel- ton, which will be effective February 1, 2011. Jeff Parsons, Corporate Controller, has been appointed Acting Chief Financial Officer and will assume the financial responsibilities of the Company on the effective date.
http://www.gigoptix.com
H
amaTech APE GmbH & Co. KG, a wholly owned subsidiary of SÜSS MicroTec AG (GER:
SMH), Germany, has received a double-digit number of orders for MaskTrack Pro, the mask integrity platform for Next Generation Lithography, since its launch in July 2009.
MaskTrack Pro is the only system in the field that addresses the highly critical clean, bake and develop steps for photo masks in the advanced lithography nodes as sub22nm 193nm Immersion Lithography, Extreme Ultraviolet Lithography (EUVL) and Nano- Imprint Lithography (NIL). With a unique combina- tion of physical and chemical cleaning technologies, the MaskTrack Pro enables customers to effectively remove organic and inorganic contamination without damage to the vulnerable features and material struc- tures of the reticle. MaskTrack Pro Bake Develop combines the exclusive ASonic®
develop technology
with a sophisticated Post-Exposure Bake regime for perfect CD uniformity matching, crucial to sub 22nm double patterning technology and future production challenges of advanced lithography.
http://www.hamatech-ape.de
H
amburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a
privately owned pharmaceutical development com- pany in Buenos Aires, Argentina.
Amarin has more than 20 years of experience in the technology of transdermal delivery systems and owns several patents. The mid-size company has been cooperating with HELM successfully on the development of a pain release patch.
http://www.helmag.com
H
.C. Starck and Cabot Corporation (NYSE: CBT) have signed a broad, non-exclusive worldwi-
de patent cross-license agreement allowing mutual access to tantalum and niobium powder technology portions of their respective patent portfolios. This agreement enables each company to independently focus efforts and resources on product innovation
25
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95